{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:44:33Z","timestamp":1790667873719,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,4,24]],"date-time":"2015-04-24T00:00:00Z","timestamp":1429833600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1038\/cdd.2015.47","type":"journal-article","created":{"date-parts":[[2015,4,24]],"date-time":"2015-04-24T15:24:04Z","timestamp":1429889044000},"page":"1858-1864","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Pharmacological targeting of guanosine monophosphate synthase suppresses melanoma cell invasion and tumorigenicity"],"prefix":"10.1038","volume":"22","author":[{"given":"A","family":"Bianchi-Smiraglia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J A","family":"Wawrzyniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Bagati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E K","family":"Marvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Ackroyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Moparthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Bshara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E E","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C E","family":"Foley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G E","family":"Morozevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A E","family":"Berman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D S","family":"Shewach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M A","family":"Nikiforov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,24]]},"reference":[{"key":"BFcdd201547_CR1","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1080\/07357900600817758","volume":"24","author":"B Neri","year":"2006","unstructured":"Neri B, Vannozzi L, Fulignati C, Pantaleo P, Pantalone D, Paoletti C et al. Long-term survival in metastatic melanoma patients treated with sequential biochemotherapy: report of a Phase II study. Cancer Invest 2006; 24: 474\u2013478.","journal-title":"Cancer Invest"},{"key":"BFcdd201547_CR2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1056\/NEJMra052166","volume":"355","author":"AJ Miller","year":"2006","unstructured":"Miller AJ, Mihm MC Jr. . Melanoma. N Engl J Med 2006; 355: 51\u201365.","journal-title":"N Engl J Med"},{"key":"BFcdd201547_CR3","doi-asserted-by":"publisher","first-page":"e1379","DOI":"10.1038\/cddis.2014.329","volume":"5","author":"K Kolli-Bouhafs","year":"2014","unstructured":"Kolli-Bouhafs K, Sick E, Noulet F, Gies JP, De Mey J, Ronde P . FAK competes for Src to promote migration against invasion in melanoma cells. Cell Death Dis 2014; 5: e1379.","journal-title":"Cell Death Dis"},{"key":"BFcdd201547_CR4","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1101\/gad.189365.112","volume":"26","author":"CV Dang","year":"2012","unstructured":"Dang CV . Links between metabolism and cancer. Genes Dev 2012; 26: 877\u2013890.","journal-title":"Genes Dev"},{"key":"BFcdd201547_CR5","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.gde.2009.01.002","volume":"19","author":"X Tong","year":"2009","unstructured":"Tong X, Zhao F, Thompson CB . The molecular determinants of de novo nucleotide biosynthesis in cancer cells. Curr Opin Genet Dev 2009; 19: 32\u201337.","journal-title":"Curr Opin Genet Dev"},{"key":"BFcdd201547_CR6","doi-asserted-by":"publisher","first-page":"e2722","DOI":"10.1371\/journal.pone.0002722","volume":"3","author":"YC Liu","year":"2008","unstructured":"Liu YC, Li F, Handler J, Huang CR, Xiang Y, Neretti N et al. Global regulation of nucleotide biosynthetic genes by c-Myc. PLoS ONE 2008; 3: e2722.","journal-title":"PLoS ONE"},{"key":"BFcdd201547_CR7","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.4161\/cc.6390","volume":"7","author":"S Mannava","year":"2008","unstructured":"Mannava S, Grachtchouk V, Wheeler LJ, Im M, Zhuang D, Slavina EG et al. Direct role of nucleotide metabolism in C-MYC-dependent proliferation of melanoma cells. Cell Cycle 2008; 7: 2392\u20132400.","journal-title":"Cell Cycle"},{"key":"BFcdd201547_CR8","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.celrep.2013.09.015","volume":"5","author":"JA Wawrzyniak","year":"2013","unstructured":"Wawrzyniak JA, Bianchi-Smiraglia A, Bshara W, Mannava S, Ackroyd J, Bagatis A et al. A purine nucloetide biosynthesis enzyme guanosine monophosphate reductase is a suppressor of melanoma invasion. Cell Rep 2013; 5: 493\u2013507.","journal-title":"Cell Rep"},{"key":"BFcdd201547_CR9","doi-asserted-by":"publisher","first-page":"e877","DOI":"10.1038\/cddis.2013.393","volume":"4","author":"PM Tedeschi","year":"2013","unstructured":"Tedeschi PM, Markert EK, Gounder M, Lin H, Dvorzhinski D, Dolfi SC et al. Contribution of serine, folate and glycine metabolism to the ATP, NADPH and purine requirements of cancer cells. Cell Death Dis 2013; 4: e877.","journal-title":"Cell Death Dis"},{"key":"BFcdd201547_CR10","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/j.1875-9114.1997.tb03082.x","volume":"17","author":"TM Sievers","year":"1997","unstructured":"Sievers TM, Rossi SJ, Ghobrial RM, Arriola E, Nishimura P, Kawano M et al. Mycophenolate mofetil. Pharmacotherapy 1997; 17: 1178\u20131197.","journal-title":"Pharmacotherapy"},{"key":"BFcdd201547_CR11","first-page":"85","volume":"30","author":"MJ Sweeney","year":"1977","unstructured":"Sweeney MJ . Mycophenolic acid and its mechanism of action in cancer and psoriasis. Jpn J Antibiot 1977; 30: 85\u201392.","journal-title":"Jpn J Antibiot"},{"key":"BFcdd201547_CR12","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1097\/00007691-199512000-00023","volume":"17","author":"JT Ransom","year":"1995","unstructured":"Ransom JT . Mechanism of action of mycophenolate mofetil. Ther Drug Monit 1995; 17: 681\u2013684.","journal-title":"Ther Drug Monit"},{"key":"BFcdd201547_CR13","doi-asserted-by":"publisher","first-page":"e721","DOI":"10.1038\/cddis.2013.247","volume":"4","author":"KH Huh","year":"2013","unstructured":"Huh KH, Cho Y, Kim BS, Do JH, Park YJ, Joo DJ et al. The role of thioredoxin 1 in the mycophenolic acid-induced apoptosis of insulin-producing cells. Cell Death Dis 2013; 4: e721.","journal-title":"Cell Death Dis"},{"key":"BFcdd201547_CR14","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1097\/01.tp.0000253756.69243.65","volume":"83","author":"GE Koehl","year":"2007","unstructured":"Koehl GE, Wagner F, Stoeltzing O, Lang SA, Steinbauer M, Schlitt HJ et al. Mycophenolate mofetil inhibits tumor growth and angiogenesis in vitro but has variable antitumor effects in vivo, possibly related to bioavailability. Transplantation 2007; 83: 607\u2013614.","journal-title":"Transplantation"},{"key":"BFcdd201547_CR15","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s10637-012-9822-x","volume":"31","author":"J Rodriguez-Pascual","year":"2013","unstructured":"Rodriguez-Pascual J, Sha P, Garcia-Garcia E, Rajeshkumar NV, De Vicente E, Quijano Y et al. A preclinical and clinical study of mycophenolate mofetil in pancreatic cancer. Invest New Drugs 2013; 31: 14\u201319.","journal-title":"Invest New Drugs"},{"key":"BFcdd201547_CR16","doi-asserted-by":"crossref","first-page":"23830","DOI":"10.1016\/S0021-9258(17)31590-9","volume":"269","author":"M Hirst","year":"1994","unstructured":"Hirst M, Haliday E, Nakamura J, Lou L . Human GMP synthetase. Protein purification, cloning, and functional expression of cDNA. J Biol Chem 1994; 269: 23830\u201323837.","journal-title":"J Biol Chem"},{"key":"BFcdd201547_CR17","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0076-6879(85)13037-5","volume":"113","author":"H Zalkin","year":"1985","unstructured":"Zalkin H . GMP synthetase. Methods Enzymol 1985; 113: 273\u2013278.","journal-title":"Methods Enzymol"},{"key":"BFcdd201547_CR18","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1534\/genetics.105.042911","volume":"172","author":"H Long","year":"2006","unstructured":"Long H, Cameron S, Yu L, Rao Y . De novo GMP synthesis is required for axon guidance in Drosophila. Genetics 2006; 172: 1633\u20131642.","journal-title":"Genetics"},{"key":"BFcdd201547_CR19","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.chembiol.2007.09.009","volume":"14","author":"R Rodriguez-Suarez","year":"2007","unstructured":"Rodriguez-Suarez R, Xu D, Veillette K, Davison J, Sillaots S, Kauffman S et al. Mechanism-of-action determination of GMP synthase inhibitors and target validation in Candida albicans and Aspergillus fumigatus. Chem Biol 2007; 14: 1163\u20131175.","journal-title":"Chem Biol"},{"key":"BFcdd201547_CR20","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1128\/JB.02131-12","volume":"195","author":"S Tojo","year":"2013","unstructured":"Tojo S, Hirooka K, Fujita Y . Expression of kinA and kinB of Bacillus subtilis, necessary for sporulation initiation, is under positive stringent transcription control. J Bacteriol 2013; 195: 1656\u20131665.","journal-title":"J Bacteriol"},{"key":"BFcdd201547_CR21","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.molcel.2011.06.034","volume":"44","author":"AC Faesen","year":"2011","unstructured":"Faesen AC, Dirac AM, Shanmugham A, Ovaa H, Perrakis A, Sixma TK . Mechanism of USP7\/HAUSP activation by its C-terminal ubiquitin-like domain and allosteric regulation by GMP-synthetase. Mol Cell 2011; 44: 147\u2013159.","journal-title":"Mol Cell"},{"key":"BFcdd201547_CR22","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.molcel.2013.12.017","volume":"53","author":"BA Reddy","year":"2014","unstructured":"Reddy BA, van der Knaap JA, Bot AG, Mohd-Sarip A, Dekkers DH, Timmermans MA et al. Nucleotide biosynthetic enzyme GMP synthase is a TRIM21-controlled relay of p53 stabilization. Mol Cell 2014; 53: 458\u2013470.","journal-title":"Mol Cell"},{"key":"BFcdd201547_CR23","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1128\/MCB.01121-09","volume":"30","author":"JA van der Knaap","year":"2010","unstructured":"van der Knaap JA, Kozhevnikova E, Langenberg K, Moshkin YM, Verrijzer CP . Biosynthetic enzyme GMP synthetase cooperates with ubiquitin-specific protease 7 in transcriptional regulation of ecdysteroid target genes. Mol Cell Biol 2010; 30: 736\u2013744.","journal-title":"Mol Cell Biol"},{"key":"BFcdd201547_CR24","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.molcel.2005.02.013","volume":"17","author":"JA van der Knaap","year":"2005","unstructured":"van der Knaap JA, Kumar BR, Moshkin YM, Langenberg K, Krijgsveld J, Heck AJ et al. GMP synthetase stimulates histone H2B deubiquitylation by the epigenetic silencer USP7. Mol Cell 2005; 17: 695\u2013707.","journal-title":"Mol Cell"},{"key":"BFcdd201547_CR25","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1128\/JB.144.3.1119-1125.1980","volume":"144","author":"N Vasantha","year":"1980","unstructured":"Vasantha N, Freese E . Enzyme changes during Bacillus subtilis sporulation caused by deprivation of guanine nucleotides. J Bacteriol 1980; 144: 1119\u20131125.","journal-title":"J Bacteriol"},{"key":"BFcdd201547_CR26","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1093\/oxfordjournals.jbchem.a133759","volume":"91","author":"K Ikehara","year":"1982","unstructured":"Ikehara K, Okamoto M, Sugae K . Induction of Bacillus subtilis sporulation by decoyinine and the concomitant disappearance of ppGpp in vegetative cells. J Biochem 1982; 91: 1089\u20131092.","journal-title":"J Biochem"},{"key":"BFcdd201547_CR27","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/S0006-291X(77)80094-6","volume":"77","author":"T Mitani","year":"1977","unstructured":"Mitani T, Heinze JE, Freese E . Induction of sporulation in Bacillus subtilis by decoyinine or hadacidin. Biochem Biophys Res Commun 1977; 77: 1118\u20131125.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFcdd201547_CR28","doi-asserted-by":"publisher","first-page":"5867","DOI":"10.1128\/jb.169.12.5867-5869.1987","volume":"169","author":"WL Nicholson","year":"1987","unstructured":"Nicholson WL, Chambliss GH . Effect of decoyinine on the regulation of alpha-amylase synthesis in Bacillus subtilis. J Bacteriol 1987; 169: 5867\u20135869.","journal-title":"J Bacteriol"},{"key":"BFcdd201547_CR29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1128\/JB.154.1.261-268.1983","volume":"154","author":"B Uratani","year":"1983","unstructured":"Uratani B, Lopez JM, Freese E . Effect of decoyinine on peptidoglycan synthesis and turnover in Bacillus subtilis. J Bacteriol 1983; 154: 261\u2013268.","journal-title":"J Bacteriol"},{"key":"BFcdd201547_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0092-8674(03)00513-0","volume":"114","author":"KB Hotary","year":"2003","unstructured":"Hotary KB, Allen ED, Brooks PC, Datta NS, Long MW, Weiss SJ . Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell 2003; 114: 33\u201345.","journal-title":"Cell"},{"key":"BFcdd201547_CR31","doi-asserted-by":"publisher","first-page":"315","DOI":"10.7164\/antibiotics.22.315","volume":"22","author":"H Yamaki","year":"1969","unstructured":"Yamaki H, Tanaka N, Umezawa H . Effects of several tumor-inhibitory antibiotics on immunological responses. J Antibiot (Tokyo) 1969; 22: 315\u2013321.","journal-title":"J Antibiot (Tokyo)"},{"key":"BFcdd201547_CR32","first-page":"195","volume":"9","author":"H Yuntsen","year":"1956","unstructured":"Yuntsen H, Ohkuma K, Ishii Y, Yonehara H . Studies on angustmycin. III. J Antibiot (Tokyo) 1956; 9: 195\u2013201.","journal-title":"J Antibiot (Tokyo)"},{"key":"BFcdd201547_CR33","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2174\/092986730607220401122851","volume":"6","author":"HN Jayaram","year":"1999","unstructured":"Jayaram HN, Cooney DA, Grusch M, Krupitza G . Consequences of IMP dehydrogenase inhibition, and its relationship to cancer and apoptosis. Curr Med Chem 1999; 6: 561\u2013574.","journal-title":"Curr Med Chem"},{"key":"BFcdd201547_CR34","first-page":"258","volume":"52","author":"M Nagai","year":"1992","unstructured":"Nagai M, Natsumeda Y, Weber G . Proliferation-linked regulation of type II IMP dehydrogenase gene in human normal lymphocytes and HL-60 leukemic cells. Cancer Res 1992; 52: 258\u2013261.","journal-title":"Cancer Res"},{"key":"BFcdd201547_CR35","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1600-065X.1993.tb00652.x","volume":"136","author":"AC Allison","year":"1993","unstructured":"Allison AC, Eugui EM . Immunosuppressive and other effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil. Immunol Rev 1993; 136: 5\u201328.","journal-title":"Immunol Rev"},{"key":"BFcdd201547_CR36","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1021\/cr990097b","volume":"100","author":"R Bentley","year":"2000","unstructured":"Bentley R . Mycophenolic Acid: a one hundred year odyssey from antibiotic to immunosuppressant. Chem Rev 2000; 100: 3801\u20133826.","journal-title":"Chem Rev"},{"key":"BFcdd201547_CR37","doi-asserted-by":"publisher","first-page":"358","DOI":"10.7164\/antibiotics.22.358","volume":"22","author":"A Mitsui","year":"1969","unstructured":"Mitsui A, Suzuki S . Immunosuppressive effect of mycophenolic acid. J Antibiot (Tokyo) 1969; 22: 358\u2013363.","journal-title":"J Antibiot (Tokyo)"},{"key":"BFcdd201547_CR38","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1023\/A:1015828802490","volume":"7","author":"WA Lee","year":"1990","unstructured":"Lee WA, Gu L, Miksztal AR, Chu N, Leung K, Nelson PH . Bioavailability improvement of mycophenolic acid through amino ester derivatization. Pharm Res 1990; 7: 161\u2013166.","journal-title":"Pharm Res"},{"key":"BFcdd201547_CR39","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1158\/1535-7163.MCT-08-0193","volume":"7","author":"S Domhan","year":"2008","unstructured":"Domhan S, Muschal S, Schwager C, Morath C, Wirkner U, Ansorge W et al. Molecular mechanisms of the antiangiogenic and antitumor effects of mycophenolic acid. Mol Cancer Therap 2008; 7: 1656\u20131668.","journal-title":"Mol Cancer Therap"},{"key":"BFcdd201547_CR40","first-page":"2880","volume":"6","author":"B Dun","year":"2013","unstructured":"Dun B, Xu H, Sharma A, Liu H, Yu H, Yi B et al. Delineation of biological and molecular mechanisms underlying the diverse anticancer activities of mycophenolic acid. Int J Clin Exp Pathol 2013; 6: 2880\u20132886.","journal-title":"Int J Clin Exp Pathol"},{"key":"BFcdd201547_CR41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3322\/caac.21208","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel R, Ma J, Zou Z, Jemal A . Cancer statistics, 2014. Cancer J Clin 2014; 64: 9\u201329.","journal-title":"Cancer J Clin"},{"key":"BFcdd201547_CR42","doi-asserted-by":"publisher","first-page":"e719","DOI":"10.1038\/cddis.2013.249","volume":"4","author":"H Vorsmann","year":"2013","unstructured":"Vorsmann H, Groeber F, Walles H, Busch S, Beissert S, Walczak H et al. Development of a human three-dimensional organotypic skin-melanoma spheroid model for in vitro drug testing. Cell Death Dis 2013; 4: e719.","journal-title":"Cell Death Dis"},{"key":"BFcdd201547_CR43","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3322\/caac.21235","volume":"64","author":"CE DeSantis","year":"2014","unstructured":"DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL et al. Cancer treatment and survivorship statistics, 2014. Cancer J Clin 2014; 64: 252\u2013271.","journal-title":"Cancer J Clin"},{"key":"BFcdd201547_CR44","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1038\/cddis.2010.67","volume":"1","author":"ML Marino","year":"2010","unstructured":"Marino ML, Fais S, Djavaheri-Mergny M, Villa A, Meschini S, Lozupone F et al. Proton pump inhibition induces autophagy as a survival mechanism following oxidative stress in human melanoma cells. Cell Death Dis 2010; 1: e87.","journal-title":"Cell Death Dis"},{"key":"BFcdd201547_CR45","doi-asserted-by":"publisher","first-page":"e578","DOI":"10.1038\/cddis.2013.109","volume":"4","author":"S Romano","year":"2013","unstructured":"Romano S, Staibano S, Greco A, Brunetti A, Nappo G, Ilardi G et al. FK506 binding protein 51 positively regulates melanoma stemness and metastatic potential. Cell Death Dis 2013; 4: e578.","journal-title":"Cell Death Dis"},{"key":"BFcdd201547_CR46","doi-asserted-by":"publisher","first-page":"e914","DOI":"10.1038\/cddis.2013.441","volume":"4","author":"W Hu","year":"2013","unstructured":"Hu W, Jin L, Jiang CC, Long GV, Scolyer RA, Wu Q et al. AEBP1 upregulation confers acquired resistance to BRAF (V600E) inhibition in melanoma. Cell Death Dis 2013; 4: e914.","journal-title":"Cell Death Dis"},{"key":"BFcdd201547_CR47","doi-asserted-by":"publisher","first-page":"e846","DOI":"10.1038\/cddis.2013.365","volume":"4","author":"S Wansleben","year":"2013","unstructured":"Wansleben S, Davis E, Peres J, Prince S . A novel role for the anti-senescence factor TBX2 in DNA repair and cisplatin resistance. Cell Death Dis 2013; 4: e846.","journal-title":"Cell Death Dis"},{"key":"BFcdd201547_CR48","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.18632\/oncotarget.1892","volume":"5","author":"E Shtivelman","year":"2014","unstructured":"Shtivelman E, Davies MQ, Hwu P, Yang J, Lotem M, Oren M et al. Pathways and therapeutic targets in melanoma. Oncotarget 2014; 5: 1701\u20131752.","journal-title":"Oncotarget"},{"key":"BFcdd201547_CR49","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2147\/CMAR.S49494","volume":"6","author":"M Tronnier","year":"2014","unstructured":"Tronnier M, Mitteldorf C . Treating advanced melanoma: current insights and opportunities. Cancer Manag Res 2014; 6: 349\u2013356.","journal-title":"Cancer Manag Res"},{"key":"BFcdd201547_CR50","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ajpath.2012.09.011","volume":"182","author":"S Mannava","year":"2013","unstructured":"Mannava S, Moparthy KC, Wheeler LJ, Natarajan V, Zucker SN, Fink EE et al. Depletion of deoxyribonucleotide pools is an endogenous source of DNA damage in cells undergoing oncogene-induced senescence. Am J Pathol 2013; 182: 142\u2013151.","journal-title":"Am J Pathol"},{"key":"BFcdd201547_CR51","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1038\/onc.2011.339","volume":"31","author":"S Mannava","year":"2012","unstructured":"Mannava S, Omilian AR, Wawrzyniak JA, Fink EE, Zhuang D, Miecznikowski JC et al. PP2A-B56alpha controls oncogene-induced senescence in normal and tumor human melanocytic cells. Oncogene 2012; 31: 1484\u20131492.","journal-title":"Oncogene"}],"updated-by":[{"DOI":"10.1080\/23723556.2015.1052181","type":"addendum","label":"Addendum","source":"publisher","updated":{"date-parts":[[2015,6,10]],"date-time":"2015-06-10T00:00:00Z","timestamp":1433894400000}}],"container-title":["Cell Death & Differentiation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/cdd201547.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cdd201547","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cdd201547.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T15:59:26Z","timestamp":1717862366000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cdd201547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,24]]},"references-count":51,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["BFcdd201547"],"URL":"https:\/\/doi.org\/10.1038\/cdd.2015.47","relation":{"addendum":[{"id-type":"doi","id":"10.1080\/23723556.2015.1052181","asserted-by":"object"}]},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,24]]},"assertion":[{"value":"26 February 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}